AI assistant
Vanda Pharmaceuticals Inc. — Director's Dealing 2014
Dec 5, 2014
33390_dirs_2014-12-05_6e5ec543-6956-4628-b34b-8d79e629d0c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2014-12-04
Reporting Person: Baroldi Paolo (SVP & Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-04 | Employee Stock Option (Right to Buy) | $12.27 | A | 60000 | Acquired | 2024-12-03 | Common Stock (60000) | Direct |
| 2014-12-04 | Restricted Stock Units | $ | A | 20000 | Acquired | Common Stock (20000) | Direct |
Footnotes
F1: The shares subject to this option shall vest in forty-eight (48) equal monthly installments beginning January 4, 2015, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date.
F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
F3: The RSUs shall vest in four (4) equal annual installments beginning January 1, 2016, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
F4: Not Applicable.